Fourth Time’s the Charm for Entera Bio IPO
The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each
Dror Reich | 10:24 01.07.2018
Jerusalem-based biomed company Entera Bio Ltd. listed on Nasdaq on Thursday, succeeding on its fourth attempt. The company priced 1.4 million units at $8 each, each consisting of one ordinary share and one warrant for half a share. The shares and the units separated upon issuance.
For daily updates, subscribe to our newsletter by clicking here.The pricing for the public offering range is at the lower end of the $8-$11 range, reflecting proceeds of $1.2 million, much lower than the company’s previous IPO attempts. The warrants have an exercise price of $8.40 per share.